SNCA and Parkinson disease: Trehalose enhances the clearance of mutant but not wild type α-synuclein in PC12 cells by activating autophagy [162], and nilotinib reverses motor behavior deficits and loss of dopamine neurons via autophagic degradation of α-synuclein in PD models [163].